Related references
Note: Only part of the references are listed.Upregulation of microRNA-218 reduces cardiac microvascular endothelial cells injury induced by coronary artery disease through the inhibition of HMGB1
Wenhui Gao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study
Federico Biscetti et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study
Federico Biscetti et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Catherine Owens Johnson et al.
LANCET NEUROLOGY (2019)
Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease
Federico Biscetti et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects
Federico Biscetti et al.
CARDIOVASCULAR DIABETOLOGY (2019)
High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future Perspectives
Federico Biscetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromso Study
Agnethe Eltoft et al.
ATHEROSCLEROSIS (2018)
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Paolo Raggi et al.
ATHEROSCLEROSIS (2018)
Activation of NLRP3 Inflammasome Promotes Foam Cell Formation in Vascular Smooth Muscle Cells and Atherogenesis Via HMGB1
Rui Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
The angiogenic properties of human adipose-derived stem cells (HASCs) are modulated by the High mobility group box protein 1 (HMGB1)
Federico Biscetti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects
Silvia Giovannini et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Roles of High Mobility Group Box 1 in Cardiovascular Calcification
Qiang Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications
Han Wu et al.
MEDIATORS OF INFLAMMATION (2016)
Carotid Atherosclerotic Plaque Characteristics on Magnetic Resonance Imaging Relate With History of Stroke and Coronary Heart Disease
Mariana Selwaness et al.
STROKE (2016)
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model
Andrea Flex et al.
THROMBOSIS RESEARCH (2016)
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis
Federico Biscetti et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Inflammation and plaque vulnerability
G. K. Hansson et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Identification of a potential proinflammatory genetic profile influencing carotid plaque vulnerability
Federico Biscetti et al.
JOURNAL OF VASCULAR SURGERY (2015)
Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis
Enrico Ammirati et al.
MEDIATORS OF INFLAMMATION (2015)
Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice
Ki Churl Chang
THROMBOSIS RESEARCH (2015)
TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes
Federico Biscetti et al.
ACTA DIABETOLOGICA (2014)
Plaque Inflammation and Unstable Morphology Are Associated With Early Stroke Recurrence in Symptomatic Carotid Stenosis
Michael Marnane et al.
STROKE (2014)
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism
Federico Biscetti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ
Federico Biscetti et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Carotid Artery Stenosis as a Cause of Stroke
Matthew L. Flaherty et al.
NEUROEPIDEMIOLOGY (2013)
Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor
Jing Chen et al.
ATHEROSCLEROSIS (2012)
HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease
Martin Andrassy et al.
PLOS ONE (2012)
The high mobility group box: the ultimate utility player of a cell
Christopher S. Malarkey et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E-Deficient Mice
Peter Kanellakis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Therapeutic Potential of High Mobility Group Box-1 in Ischemic Injury and Tissue Regeneration
Federico Biscetti et al.
CURRENT VASCULAR PHARMACOLOGY (2011)
HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction
M. Andrassy et al.
JOURNAL OF INTERNAL MEDICINE (2011)
High-Mobility Group Box-1 Protein Promotes Angiogenesis After Peripheral Ischemia in Diabetic Mice Through a VEGF-Dependent Mechanism
Federico Biscetti et al.
DIABETES (2010)
Increased serum HMGB1 is related to the severity of coronary artery stenosis
Xiaorong Hu et al.
CLINICA CHIMICA ACTA (2009)
High-mobility group box-1 in ischemia-reperfusion injury of the heart
Martin Andrassy et al.
CIRCULATION (2008)
Markers of Inflammation in Patients With Symptomatic and Asymptomatic Carotid Artery Stenosis: A Case-Control Study
Erik Debing et al.
VASCULAR AND ENDOVASCULAR SURGERY (2008)
Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice
Jacob F. Bentzon et al.
CIRCULATION (2007)
HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques
Katsumi Inoue et al.
CARDIOVASCULAR PATHOLOGY (2007)
Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein
Annalisa Porto et al.
FASEB JOURNAL (2006)
Responsiveness to cholinesterase inhibitors in Alzheimer's disease: A possible role for the 192 Q/R polymorphism of the PON-1 gene
R Pola et al.
NEUROSCIENCE LETTERS (2005)
Inflammation and carotid artery - Risk for atherosclerosis study (ICARAS)
M Schillinger et al.
CIRCULATION (2005)
Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke - The Rotterdam Study
HHS Oei et al.
CIRCULATION (2005)
HMGB1 is an endogenous immune adjuvant released by necrotic cells
P Rovere-Querini et al.
EMBO REPORTS (2004)
Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions - Role of activated macrophages and cytokines
N Kalinina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Lessons from sudden coronary death - A comprehensive morphological classification scheme for atherosclerotic lesions
R Virmani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
